Skip to main content
. 2020 Dec 15;16(12):2047–2062. doi: 10.5664/jcsm.8750

Table 4.

Clinical measures by diagnosis.

Measure n Baseline Posttreatment t P d
PHQ
 NT1 12 14.33 (4.98) 10.58 (6.50) −2.92 .0140 −0.84
 NT2 11 13.45 (4.08) 10.09 (4.87) −2.14 .0576 −0.65
 IH 12 14.42 (3.73) 11.75 (4.59) −2.50 .0297 −0.72
PROMIS
 Dep
  NT1 12 59.91 (7.51) 56.00 (10.09) −1.81 .0984 −0.52
  NT2 11 60.50 (7.40) 59.01 (10.00) −0.77 .4576 −0.23
  IH 12 59.57 (4.99) 57.94 (7.46) −0.82 .4302 −0.24
 Anx
  NT1 12 64.40 (5.83) 60.28 (8.69) −1.99 .0726 −0.57
  NT2 11 62.45 (10.73) 62.29 (9.54) −0.08 .9381 −0.02
  IH 12 59.67 (5.74) 58.09 (5.13) −0.98 .3409 −0.28
 Sleep Dist
  NT1 12 57.30 (7.68) 57.23 (9.11) −0.05 .9618 −0.01
  NT2 11 57.09 (7.06) 53.46 (6.28) −2.23 .0501 −0.67
  IH 12 49.89 (5.12) 49.96 (6.61) 0.05 .9638 0.01
 Sleep Imp
  NT1 12 68.66 (4.99) 65.85 (8.46) −1.64 .1295 −0.47
  NT2 11 61.59 (5.80) 60.35 (3.15) −0.86 .4119 −0.26
  IH 12 63.38 (7.41) 64.30 (4.60) 0.36 .7256 0.10
 Fatigue
  NT1 12 69.37 (4.08) 67.32 (7.26) −1.30 .2206 −0.37
  NT2 11 63.16 (7.95) 63.24 (7.91) 0.04 .9652 0.01
  IH 12 68.71 (4.96) 67.97 (5.43) −0.42 .6801 −0.12
 GSE
  NT1 12 39.29 (10.80) 45.09 (8.37) 2.84 .0160 0.82
  NT2 11 41.14 (7.20) 42.33 (8.49) 0.58 .5731 0.18
  IH 12 40.09 (7.74) 45.92 (6.96) 2.90 .0145 0.84
 SEMEM
  NT1 12 41.77 (7.19) 45.80 (7.88) 2.31 .0415 0.67
  NT2 11 40.39 (4.82) 40.96 (6.53) 0.31 .7655 0.09
  IH 12 41.03 (4.28) 42.38 (6.52) 1.09 .2977 0.32
 SEMSS
  NT1 12 41.18 (7.31) 44.27 (6.36) 2.97 .0127 0.86
  NT2 11 41.01 (8.37) 42.58 (7.15) 0.92 .3797 0.28
  IH 12 42.56 (4.90) 42.24 (3.54) −0.40 .6990 −0.11
 SEMSX
  NT1 12 38.52 (5.98) 42.23 (6.31) 3.84 .0028 1.11
  NT2 11 40.16 (6.20) 39.36 (4.03) −0.34 .7428 −0.10
  IH 12 38.18 (4.55) 39.54 (4.24) 1.05 .3183 0.30
 Participate
  NT1 12 37.21 (6.61) 38.03 (6.54) 0.93 .3721 0.27
  NT2 11 38.81 (8.38) 40.68 (5.25) 1.17 .2689 0.35
  IH 12 39.13 (4.28) 39.43 (3.70) 0.29 .7765 0.08
 Soc Isolation
  NT1 12 59.58 (5.84) 54.48 (5.90) −3.48 .0051 −1.01
  NT2 11 58.85 (6.90) 57.41 (5.76) −0.69 .5074 −0.21
  IH 12 57.16 (5.41) 57.90 (8.29) 0.53 .6068 0.15
 Cog Funct
  NT1 12 34.72 (5.09) 37.24 (4.25) 2.30 .0419 0.66
  NT2 11 40.12 (5.67) 37.62 (3.75) −1.99 .0749 −0.60
  IH 12 35.73 (4.83) 37.48 (4.81) 1.05 .3143 0.30
 Phys Funct
  NT1 12 43.08 (5.29) 43.26 (6.94) 0.11 .9135 0.03
  NT2 11 42.75 (6.02) 44.19 (8.08) 1.81 .0998 0.55
  IH 12 44.81 (7.19) 43.49 (6.54) −1.39 .1908 −0.40
 Global MH
  NT1 12 33.71 (7.35) 37.30 (7.90) 2.34 .0390 0.67
  NT2 11 37.78 (7.88) 38.37 (7.22) 0.21 .8383 0.06
  IH 12 37.74 (4.96) 37.19 (7.61) −0.32 .7584 −0.09
 Global PH
  NT1 12 42.18 (6.31) 41.63 (7.04) −0.63 .5421 −0.18
  NT2 11 42.80 (8.96) 43.12 (7.09) 0.19 .8522 0.06
  IH 12 42.53 (7.92) 42.13 (4.30) −0.22 .8310 −0.06
ESS
 NT1 12 15.00 (3.25) 13.92 (3.48) −2.17 .0528 −0.63
 NT2 11 10.55 (2.70) 10.64 (3.35) 0.09 .9309 0.03
 IH 12 13.83 (3.76) 11.83 (3.64) −2.10 .0598 −0.61
FOSQ
 Activity
  NT1 12 1.93 (0.43) 1.97 (0.62) 0.48 .6430 0.14
  NT2 11 2.19 (0.43) 2.21 (0.71) 0.10 .9212 0.03
  IH 12 1.78 (0.38) 1.99 (0.46) 1.48 .1665 0.43
 Vigilance
  NT1 12 2.27 (0.63) 2.38 (0.69) 0.63 .5431 0.18
  NT2 11 2.61 (0.58) 2.89 (0.52) 1.51 .1619 0.46
  IH 12 2.36 (0.68) 2.43 (0.66) 0.44 .6667 0.13
 Intimacy
  NT1 12 2.23 (0.94) 2.40 (0.91) 1.23 .2437 0.36
  NT2 9 2.50 (0.83) 2.58 (1.03) 0.35 .7328 0.12
  IH 11 2.55 (0.93) 2.71 (0.87) 0.65 .5301 0.20
 Productivity
  NT1 12 2.33 (0.59) 2.39 (0.65) 0.74 .4774 0.21
  NT2 11 2.75 (0.70) 2.80 (0.43) 0.30 .7733 0.09
  IH 12 2.41 (0.47) 2.47 (0.46) 0.36 .7278 0.10
 Social
  NT1 12 2.54 (0.92) 2.67 (0.78) 0.67 .5152 0.19
  NT2 11 2.64 (0.67) 2.95 (0.52) 1.47 .1717 0.44
  IH 12 2.29 (0.72) 2.83 (0.69) 2.24 .0468 0.65
 Total FOSQ
  NT1 12 2.19 (0.41) 2.27 (0.57) 1.05 .3147 0.30
  NT2 11 2.50 (0.45) 2.62 (0.43) 0.77 .4581 0.23
  IH 12 2.21 (0.39) 2.33 (0.46) 1.16 .2688 0.34
SIQ
 NT1 12 81.08 (10.77) 76.25 (13.88) −2.22 .0487 −0.64
 NT2 11 71.64 (12.48) 70.00 (17.45) −0.43 .6789 −0.13
 IH 12 84.42 (11.91) 80.75 (14.21) −1.14 .2777 −0.33
RSQ
 NT1 12 26.56 (12.82) 27.08 (16.50) 0.15 .8808 0.04
 NT2 11 27.27 (13.48) 25.57 (12.95) −0.82 .4316 −0.25
 IH 12 11.46 (7.46) 17.71 (16.39) 1.24 .2412 0.36

PHQ = Patient Health Questionnaire, NT1 = narcolepsy type 1, NT2 = narcolepsy type 2, IH = idiopathic hypersomnia, PROMIS = Patient-Reported Outcomes Measurement Information Systems, Dep = Depression, Anx = Anxiety, Sleep Dist = Sleep Disturbance, Sleep Imp = Sleep-Related Impairment, GSE = General Self-Efficacy, SEMEM = Self-Efficacy for Managing Emotions, SEMSS = Self-Efficacy for Managing Social Interactions, SEMSX = Self-Efficacy for Managing Symptoms, Participate = Ability to Participate in Social Roles and Activities, Soc Isolation = Social Isolation, Cog Funct = Cognitive Functioning, Phys Funct = Physical Functioning, Global MH = Global Mental Health, Global PH = Global Physical Health, ESS = Epworth Sleepiness Scale, FOSQ = Functional Outcomes of Sleep Questionnaire, SIQ = Sleep Inertia Questionnaire, RSQ = Restorative Sleep Questionnaire.